help button home button Am J Pathol sign up for etoc
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mavalia, C.
Right arrow Articles by Romagnani, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mavalia, C.
Right arrow Articles by Romagnani, S.

American Journal of Pathology, Vol 151, 1751-1758, Copyright © 1997 by American Society for Investigative Pathology


REGULAR ARTICLES

Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis

C Mavalia, C Scaletti, P Romagnani, AM Carossino, A Pignone, L Emmi, C Pupilli, G Pizzolo, E Maggi and S Romagnani
Institute of Internal Medicine and Immunoallergology, University of Florence, Italy.

The pattern of cytokine production of skin-infiltrating T cells from patients with progressive systemic sclerosis was investigated. Most CD4+ T-cell clones generated from skin biopsy specimens showed a type 2 helper (Th2) cytokine profile (production of interleukin-4, but no interferon (IFN)-gamma). High interleukin-4 but little or no IFN-gamma mRNA expression was found by in situ hybridization in skin perivascular mononuclear cell infiltrates. The immunohistochemical analysis revealed CD30 expression by high numbers of CD4+ T cells in the same specimens. Finally, the great majority of patients with diffuse disease had elevated levels of soluble CD30 in their sera. These data suggest the existence in patients with progressive systemic sclerosis of a predominant activation of Th2-like T cells, which may account for the major alterations (endothelial cell injury, fibrosis, and autoantibody production) occurring in this disease.


This article has been cited by other articles:


Home page
BloodHome page
R. Zeiser, V. H. Nguyen, J.-Z. Hou, A. Beilhack, E. Zambricki, M. Buess, C. H. Contag, and R. S. Negrin
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease
Blood, March 1, 2007; 109(5): 2225 - 2233.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S Veeraraghavan, E A Renzoni, H Jeal, M Jones, J Hammer, A U Wells, C M Black, K I Welsh, and R M du Bois
Mapping of the immunodominant T cell epitopes of the protein topoisomerase I
Ann Rheum Dis, August 1, 2004; 63(8): 982 - 987.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Benagiano, A. Azzurri, A. Ciervo, A. Amedei, C. Tamburini, M. Ferrari, J. L. Telford, C. T. Baldari, S. Romagnani, A. Cassone, et al.
T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions
PNAS, May 27, 2003; 100(11): 6658 - 6663.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
R. Gerli, C. Lunardi, and C. Pitzalis
Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis
Rheumatology, December 1, 2002; 41(12): 1341 - 1345.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. F. Panus, C. A. Smith, C. A. Ray, T. D. Smith, D. D. Patel, and D. J. Pickup
Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue
PNAS, June 11, 2002; 99(12): 8348 - 8353.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. R. Chung, T. Chitnis, R. J. Panzo, D. L. Kasper, M. H. Sayegh, and A. O. Tzianabos
CD4+ T Cells Regulate Surgical and Postinfectious Adhesion Formation
J. Exp. Med., June 3, 2002; 195(11): 1471 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. I. Sakkas, B. Xu, C. M. Artlett, S. Lu, S. A. Jimenez, and C. D. Platsoucas
Oligoclonal T Cell Expansion in the Skin of Patients with Systemic Sclerosis
J. Immunol., April 1, 2002; 168(7): 3649 - 3659.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Barbano, F. Cappa, I. Prigione, V. Pistoia, A. Cohen, S. Chiesa, R. Gusmano, and F. Perfumo
Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone
Nephrol. Dial. Transplant., September 1, 2001; 16(9): 1807 - 1813.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Muta, L. H. Boise, L. Fang, and E. R. Podack
CD30 Signals Integrate Expression of Cytotoxic Effector Molecules, Lymphocyte Trafficking Signals, and Signals for Proliferation and Apoptosis
J. Immunol., November 1, 2000; 165(9): 5105 - 5111.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. E. Kadin
Regulation of CD30 Antigen Expression and Its Potential Significance for Human Disease
Am. J. Pathol., May 1, 2000; 156(5): 1479 - 1484.
[Full Text] [PDF]


Home page
J. Immunol.Home page
R. Gerli, C. Pitzalis, O. Bistoni, B. Falini, V. Costantini, A. Russano, and C. Lunardi
CD30+ T Cells in Rheumatoid Synovitis: Mechanisms of Recruitment and Functional Role
J. Immunol., April 15, 2000; 164(8): 4399 - 4407.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Romagnani, A. De Paulis, C. Beltrame, F. Annunziato, V. Dente, E. Maggi, S. Romagnani, and G. Marone
Tryptase-Chymase Double-Positive Human Mast Cells Express the Eotaxin Receptor CCR3 and Are Attracted by CCR3-Binding Chemokines
Am. J. Pathol., October 1, 1999; 155(4): 1195 - 1204.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Iijima, I. Takahashi, D. Kishi, J.-K. Kim, S. Kawano, M. Hori, and H. Kiyono
Alteration of Interleukin 4 Production Results in the Inhibition of T Helper Type 2 Cell–dominated Inflammatory Bowel Disease in T Cell Receptor {alpha} Chain–deficient Mice
J. Exp. Med., September 6, 1999; 190(5): 607 - 616.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Scala, M. Carbonari, P. Del Porto, M. Cibati, T. Tedesco, A. M. Mazzone, R. Paganelli, and M. Fiorilli
Lymphocyte Activation Gene-3 (LAG-3) Expression and IFN-{gamma} Production Are Variably Coregulated in Different Human T Lymphocyte Subpopulations
J. Immunol., July 1, 1998; 161(1): 489 - 493.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.